racemetirosine has been researched along with Anterior Circulation Transient Ischemic Attack in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marie, C | 1 |
| Mossiat, C | 1 |
| Beley, A | 1 |
| Bralet, J | 1 |
1 other study available for racemetirosine and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Alpha-methyl-para-tyrosine pretreatment protects from striatal neuronal death induced by four-vessel occlusion in the rat.
Topics: alpha-Methyltyrosine; Animals; Brain; Catecholamines; Cell Death; Corpus Striatum; Ischemic Attack, | 1992 |